Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrences”

5,763 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,763 results

Not applicableStudy completedNCT03923400
What this trial is testing

Jejunoileal vs Gastric GIST in the Era of Imatinib.

Who this might be right for
Disease-free SurvivalOverall SurvivalRecurrence
Hospital Universitario Virgen de la Arrixaca 77
Not applicableLooking for participantsNCT06076811
What this trial is testing

DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies

Who this might be right for
Colorectal NeoplasmsColorectal CancerColorectal Adenocarcinoma+3 more
University of Aarhus 1,600
Not applicableStudy completedNCT05037136
What this trial is testing

Remote Monitoring of AF Recurrence Using mHealth Technology

Who this might be right for
Long Standing Persistent Atrial Fibrillation
Royal Brompton & Harefield NHS Foundation Trust 35
Very early researchActive Not RecruitingNCT05634707
What this trial is testing

Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)

Who this might be right for
Primary Brain TumorBrain Tumor, Recurrent
Duke University 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06648200
What this trial is testing

Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Extensive StageSmall Cell Lung Cancer Recurrent
Shanghai Pulmonary Hospital, Shanghai, China 100
Large-scale testing (Phase 3)Study completedNCT01305200
What this trial is testing

Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant

Who this might be right for
Childhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Chronic Myelogenous Leukemia+24 more
Children's Oncology Group 226
Early research (Phase 1)Ended earlyNCT06304636
What this trial is testing

Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaRelapsed Multiple Myeloma
Cartesian Therapeutics 4
Early research (Phase 1)Active Not RecruitingNCT05363800
What this trial is testing

Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma

Who this might be right for
Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma
Jiangsu HengRui Medicine Co., Ltd. 74
Not applicableLooking for participantsNCT06930807
What this trial is testing

Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer

Who this might be right for
Non-small Cell Lung CancerMinimal Residual DiseaseAdaptive Treatment
Peking University People's Hospital 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07126236
What this trial is testing

Response-adaptive to Epcoritamab In First Relapse: Study to Evaluate the Efficacy of Eptoritamab in Patients With Relapse/Refractory Large B Cell Lymphoma

Who this might be right for
Large B Cell Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 80
Not applicableStudy completedNCT06265311
What this trial is testing

IDUS in CBD Stone Recurrence High Risk Patients

Who this might be right for
CholedocholithiasisCholangiopancreatography, Endoscopic RetrogradeUltrasonography
Shanghai Municipal Hospital of Traditional Chinese Medicine 248
Not applicableLooking for participantsNCT07570407
What this trial is testing

Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation

Who this might be right for
Allogeneic HSCTPosttransplant ComplicationsGvHD+2 more
University Hospital Pilsen 75
Testing effectiveness (Phase 2)Study completedNCT02301611
What this trial is testing

Phase IIB TL + YCWP + DC in Melanoma

Who this might be right for
Melanoma
Elios Therapeutics, LLC 187
Early research (Phase 1)Not Yet RecruitingNCT06500507
What this trial is testing

QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Qilu Pharmaceutical Co., Ltd. 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07644208
What this trial is testing

PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatocellular Carcinoma After Curative Hepatectomy

Who this might be right for
Hepatocellular Carcinoma (HCC)
Shanghai Zhongshan Hospital 30
Not applicableStudy completedNCT05300789
What this trial is testing

Metachonous Peritoneal Carcinomatosis Incidence After Curative Surgery for pT4 Colon Cancer Patients

Who this might be right for
Peritoneal CarcinomatosisColon Cancer
Carlos Cerdán Santacruz 1,152
Testing effectiveness (Phase 2)Study completedNCT03664635
What this trial is testing

MB-CART20.1 Lymphoma

Who this might be right for
Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaB-cell Lymphoma Refractory+1 more
Miltenyi Biomedicine GmbH 10
Large-scale testing (Phase 3)Study completedNCT05831189
What this trial is testing

A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile Infection Recurrence
Ferring Pharmaceuticals 41
Testing effectiveness (Phase 2)Study completedNCT00405743
What this trial is testing

A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesAML
Clavis Pharma 153
Early research (Phase 1)Study completedNCT01294735
What this trial is testing

Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)

Who this might be right for
Recurrence of Solid TumorGlioblastoma MultiformeMelanoma
Merck Sharp & Dohme LLC 19
Next Page